RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX)
CUSIP: 75629V104
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Class A Stock
- Shares outstanding
- 525,302,736
- Total 13F shares
- 310,182,949
- Share change
- +5,455,034
- Total reported value
- $1,569,493,304
- Put/Call ratio
- 80%
- Price per share
- $5.06
- Number of holders
- 329
- Value change
- +$26,510,398
- Number of buys
- 164
- Number of sells
- 147
Quarterly Holders Quick Answers
What is CUSIP 75629V104?
CUSIP 75629V104 identifies RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75629V104:
Top shareholders of RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARK Investment Management LLC |
13F
|
Company |
6.6%
|
34,815,502
|
$184,174,004 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.1%
|
32,287,977
|
$170,803,398 | — | 31 Mar 2025 | |
| Lux Ventures IV, L.P. |
3/4/5
|
Former 10% Owner |
—
class O/S missing
|
13,021,519
|
$137,710,376 | — | 07 Dec 2021 | |
| Mubadala Investment Co PJSC |
3/4/5
13F
|
10%+ Owner · Company |
2.5%
from 13F
|
12,985,927
|
$137,333,970 | — | 02 Mar 2023 | |
| BAILLIE GIFFORD & CO |
13F
13D/G
|
Company |
6.5%
from 13D/G
|
24,393,015
|
$129,039,050 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
4.5%
|
23,506,589
|
$124,349,857 | — | 31 Mar 2025 | |
| SOFTBANK GROUP CORP. |
13F
|
Company |
2.8%
|
14,667,491
|
$77,591,027 | — | 31 Mar 2025 | |
| Kinnevik AB (publ) |
13F
|
Company |
2.6%
|
13,434,171
|
$71,066,765 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.5%
|
13,085,258
|
$69,221,015 | — | 31 Mar 2025 | |
| Novo Holdings A/S |
13F
|
Company |
1.8%
|
9,665,128
|
$51,128,527 | — | 31 Mar 2025 | |
| MIC Capital Management UK LLP |
13F
|
Company |
1.8%
|
9,644,032
|
$51,016,935 | — | 31 Mar 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
1.6%
|
8,479,284
|
$44,855,412 | — | 31 Mar 2025 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
1.6%
|
8,407,334
|
$44,390,724 | — | 31 Mar 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
— |
2%
|
7,725,096
|
$44,187,549 | $0 | 31 Dec 2024 | |
| NVIDIA CORP |
13F
|
Company |
1.5%
|
7,706,363
|
$40,766,660 | — | 31 Mar 2025 | |
| Zachary Bogue |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
3,736,341
|
$39,514,048 | — | 03 Jul 2023 | |
| FMR LLC |
13F
|
Company |
1.3%
|
6,846,842
|
$36,219,796 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
6,443,980
|
$34,096,955 | — | 31 Mar 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.2%
|
6,408,524
|
$33,901,092 | — | 31 Mar 2025 | |
| Data Collective IV GP, LLC |
13F
|
Company |
1.1%
|
5,941,120
|
$31,428,525 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
1.1%
|
5,569,782
|
$29,464,147 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.95%
|
5,010,433
|
$26,505,195 | — | 31 Mar 2025 | |
| DCVC Opportunity Fund II GP, LLC |
13F
|
Company |
0.75%
|
3,951,141
|
$20,901,536 | — | 31 Mar 2025 | |
| Lingotto Investment Management LLP |
13F
|
Company |
0.7%
|
3,675,077
|
$19,441,157 | — | 31 Mar 2025 | |
| MIC Capital Partners (Public) Parallel Cayman, LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,388,889
|
$14,688,335 | — | 01 Nov 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.51%
|
2,655,711
|
$14,048,711 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.46%
|
2,395,188
|
$12,670,544 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.43%
|
2,278,401
|
$12,052,741 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.39%
|
2,049,611
|
$10,842,442 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.36%
|
1,912,620
|
$10,117,759 | — | 31 Mar 2025 | |
| Michael Secora |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
1,836,074
mixed-class rows
|
$9,186,510 | — | 15 Nov 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.33%
|
1,716,775
|
$9,086,919 | — | 31 Mar 2025 | |
| Laurion Capital Management LP |
13F
|
Company |
0.29%
|
1,547,407
|
$8,185,783 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.28%
|
1,495,863
|
$7,913,115 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.24%
|
1,284,962
|
$6,797,449 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.22%
|
1,152,626
|
$6,097,392 | — | 31 Mar 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.2%
|
1,031,499
|
$5,456,629 | — | 31 Mar 2025 | |
| Comprehensive Financial Management LLC |
13F
|
Company |
0.18%
|
941,895
|
$4,982,625 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.16%
|
863,224
|
$4,566,456 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.16%
|
818,324
|
$4,328,935 | — | 31 Mar 2025 | |
| Vestmark Advisory Solutions, Inc. |
13F
|
Company |
0.13%
|
706,239
|
$3,736,004 | — | 31 Mar 2025 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.13%
|
664,610
|
$3,515,787 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.13%
|
659,449
|
$3,488,485 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.12%
|
652,644
|
$3,452,487 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.11%
|
603,728
|
$3,193,721 | — | 31 Mar 2025 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.11%
|
598,420
|
$3,165,642 | — | 31 Mar 2025 | |
| Pivotal bioVenture Partners Investment Advisor LLC |
13F
|
Company |
0.11%
|
595,518
|
$3,150,290 | — | 31 Mar 2025 | |
| Liontrust Investment Partners LLP |
13F
|
Company |
0.11%
|
595,055
|
$3,147,841 | — | 31 Mar 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.11%
|
592,353
|
$3,133,547 | — | 31 Mar 2025 | |
| Tina Marriott |
3/4/5
|
President and COO |
—
mixed-class rows
|
954,769
mixed-class rows
|
$3,129,811 | — | 15 Nov 2024 |
Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX) as of Q2 2025
As of 30 Jun 2025,
RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX) was held by
329 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
310,182,949 shares.
The largest 10 holders included
VANGUARD GROUP INC, ARK Investment Management LLC, BlackRock, Inc., BAILLIE GIFFORD & CO, SOFTBANK GROUP CORP., KINNEVIK AB (PUBL), Mubadala Investment Co PJSC, STATE STREET CORP, NOVO HOLDINGS A/S, and MIC Capital Management UK LLP.
This page lists
332
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
330
Q2 2025 holders
329
Holder diff
-1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.